Pioneering leader at Deep Space Biology, transforming space biology data into health breakthroughs. Kimberly is a distinguished US-based entrepreneur, boasts an impressive track record with over two decades of international expertise in healthcare, technology, and AI. She serves as both a Board Member and Executive Vice President at Deep Space Biology, she plays a pivotal role in steering the company towards groundbreaking advancements. At the forefront of innovation, Deep Space Biology is responsible for the development of the cutting-edge AI Space Tech platform, Yotta™. This platform stands out for its ability to accelerate health discoveries by seamlessly connecting and utilizing space biology data. In a remarkable three-year collaboration with NASA Ames -Genelab, Deep Space Biology, achieved a historic milestone as the world's first company to standardize over two decades of space biological research. This collaboration has positioned Deep Space Biology as a leader in leveraging artificial intelligence to unlock the full potential of space-related data. Deep Space Biology harnesses the wealth of space biology data to expedite groundbreaking health discoveries on Earth and actively participate in collaborative projects with renowned health institutions, including Mayo Clinic and MD Anderson. Kimberly is a multifaceted entrepreneur who has extended her impact across various domains. As the founder of Space4Girls, a global cross-cultural non-profit organization, she is dedicated to empowering future leaders in STEM and specifically within the space industries, fostering inclusivity and diversity. Kimberly also serves as a partner at Leaders on Purpose, a London-based organization, and holds a position as a Board Member of the US-based Leaders on Purpose Foundation. In these capacities, she actively contributes to driving the purpose-first economy, aligning her work with meaningful societal impact.